Clinical

Dataset Information

0

Effect of Lidocaine Transdermal Patch as Add-On Therapy in Treatment of Oxaliplatin Induced Peripheral Neuropathy in Colorectal Cancer Patients


ABSTRACT: Oxaliplatin (OXA) is a third-generation platinum-based chemotherapeutic drug with better efficacy for colorectal carcinoma (CRC). Oxaliplatin-induced peripheral neuropathy (OIPN) is one of the most frequent dose-limiting or even treatment-terminating side effects that impair optimal treatment regimens in a significant proportion of patients from 19% to over 85%. Thus, OIPN impacts the quality of life and the patient’s survival. OIPN is a clinical challenge and healthcare professionals are facing this challenge with a limited selection of analgesics and nonpharmacological therapies. Pregabalin is a structural derivative of GABA and is one of the effective treatment modalities for OIPN. It binds with high affinity to the alpha2-delta site of voltage-gated calcium channels in central nervous system tissues and inhibits neurotransmitter release, thus producing anti-nociceptive and anti-seizure effects.

DISEASE(S): Peripheral Nervous System Diseases,Oxaliplatin Induced Peripheral Neuropathy In Cancer Patients

PROVIDER: 60652 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2018-11-04 | PXD011010 | Pride
2024-06-03 | GSE268606 | GEO
| PRJNA732671 | ENA
2006-05-05 | GSE4180 | GEO
2014-12-11 | E-GEOD-62844 | biostudies-arrayexpress
2023-05-03 | GSE196239 | GEO
2008-06-11 | E-GEOD-11208 | biostudies-arrayexpress
2015-03-03 | PXD000719 | Pride
2014-12-23 | GSE55114 | GEO
2008-04-19 | GSE11208 | GEO